

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.77685542 |
| 2 | proline biosynthetic process (GO:0006561) | 4.61643735 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.59422650 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.55702029 |
| 5 | negative regulation of cell size (GO:0045792) | 4.47920883 |
| 6 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.43361255 |
| 7 | glucose 6-phosphate metabolic process (GO:0051156) | 4.11886603 |
| 8 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 4.05731613 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.01087060 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.98135672 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.98135672 |
| 12 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.93268159 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 3.86485926 |
| 14 | positive regulation of lamellipodium assembly (GO:0010592) | 3.85212183 |
| 15 | barbed-end actin filament capping (GO:0051016) | 3.68363866 |
| 16 | vesicle coating (GO:0006901) | 3.63113568 |
| 17 | synaptic vesicle maturation (GO:0016188) | 3.62871256 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.61260759 |
| 19 | regulation of translational fidelity (GO:0006450) | 3.60103340 |
| 20 | proline metabolic process (GO:0006560) | 3.54791225 |
| 21 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.49330798 |
| 22 | COPII vesicle coating (GO:0048208) | 3.47592296 |
| 23 | pentose-phosphate shunt (GO:0006098) | 3.47147580 |
| 24 | gluconeogenesis (GO:0006094) | 3.46792522 |
| 25 | regulation of ARF GTPase activity (GO:0032312) | 3.45869462 |
| 26 | thymic T cell selection (GO:0045061) | 3.45674225 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 3.45604176 |
| 28 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.45093796 |
| 29 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.44780728 |
| 30 | natural killer cell differentiation (GO:0001779) | 3.42040024 |
| 31 | monosaccharide biosynthetic process (GO:0046364) | 3.41153946 |
| 32 | sodium ion export (GO:0071436) | 3.40988593 |
| 33 | glycolytic process (GO:0006096) | 3.36500030 |
| 34 | COPI coating of Golgi vesicle (GO:0048205) | 3.34979628 |
| 35 | Golgi transport vesicle coating (GO:0048200) | 3.34979628 |
| 36 | positive regulation of histone deacetylation (GO:0031065) | 3.34650849 |
| 37 | positive regulation of lamellipodium organization (GO:1902745) | 3.33989105 |
| 38 | regulation of defense response to virus by virus (GO:0050690) | 3.31461260 |
| 39 | hexose biosynthetic process (GO:0019319) | 3.30981183 |
| 40 | pentose metabolic process (GO:0019321) | 3.30380000 |
| 41 | mannose metabolic process (GO:0006013) | 3.29675738 |
| 42 | negative thymic T cell selection (GO:0045060) | 3.26307495 |
| 43 | protein maturation by protein folding (GO:0022417) | 3.25537396 |
| 44 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.25521897 |
| 45 | DNA deamination (GO:0045006) | 3.18984815 |
| 46 | negative regulation of cell killing (GO:0031342) | 3.18183364 |
| 47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.18183364 |
| 48 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.16386979 |
| 49 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.14893518 |
| 50 | regulation of cholesterol metabolic process (GO:0090181) | 3.14691541 |
| 51 | response to interleukin-15 (GO:0070672) | 3.14238283 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12880782 |
| 53 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.12549773 |
| 54 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.10874771 |
| 55 | endothelial tube morphogenesis (GO:0061154) | 3.06743882 |
| 56 | morphogenesis of an endothelium (GO:0003159) | 3.06743882 |
| 57 | negative T cell selection (GO:0043383) | 3.06495426 |
| 58 | maintenance of protein localization in organelle (GO:0072595) | 3.02957255 |
| 59 | nucleosome disassembly (GO:0006337) | 2.98231475 |
| 60 | protein-DNA complex disassembly (GO:0032986) | 2.98231475 |
| 61 | T cell selection (GO:0045058) | 2.95564614 |
| 62 | ncRNA 3-end processing (GO:0043628) | 2.95483808 |
| 63 | glucose catabolic process (GO:0006007) | 2.93622936 |
| 64 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.93257387 |
| 65 | regulation of RNA export from nucleus (GO:0046831) | 2.92283874 |
| 66 | regulation of extracellular matrix disassembly (GO:0010715) | 2.89972869 |
| 67 | snRNA metabolic process (GO:0016073) | 2.89866354 |
| 68 | negative regulation of microtubule polymerization (GO:0031115) | 2.89336358 |
| 69 | peptidyl-arginine N-methylation (GO:0035246) | 2.87445869 |
| 70 | peptidyl-arginine methylation (GO:0018216) | 2.87445869 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 2.85952823 |
| 72 | positive T cell selection (GO:0043368) | 2.85626896 |
| 73 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.85384608 |
| 74 | NADH metabolic process (GO:0006734) | 2.85379444 |
| 75 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.85267985 |
| 76 | fructose metabolic process (GO:0006000) | 2.84471828 |
| 77 | locomotory exploration behavior (GO:0035641) | 2.84410292 |
| 78 | negative regulation of myotube differentiation (GO:0010832) | 2.83549338 |
| 79 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.83307287 |
| 80 | cerebellar Purkinje cell layer development (GO:0021680) | 2.83179943 |
| 81 | regulation of ARF protein signal transduction (GO:0032012) | 2.82653884 |
| 82 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.82244130 |
| 83 | regulation of autophagic vacuole assembly (GO:2000785) | 2.81079495 |
| 84 | signal complex assembly (GO:0007172) | 2.80162641 |
| 85 | protein retention in ER lumen (GO:0006621) | 2.79128223 |
| 86 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.78901136 |
| 87 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.78752293 |
| 88 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.78520385 |
| 89 | NADPH regeneration (GO:0006740) | 2.78076739 |
| 90 | oxaloacetate metabolic process (GO:0006107) | 2.77492714 |
| 91 | creatine metabolic process (GO:0006600) | 2.77444123 |
| 92 | localization within membrane (GO:0051668) | 2.76103380 |
| 93 | snRNA processing (GO:0016180) | 2.75902085 |
| 94 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.75753747 |
| 95 | regulation of nuclease activity (GO:0032069) | 2.75423679 |
| 96 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.74310454 |
| 97 | cell communication by electrical coupling (GO:0010644) | 2.73307117 |
| 98 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.73300321 |
| 99 | regulation of mitotic spindle organization (GO:0060236) | 2.73104290 |
| 100 | stress fiber assembly (GO:0043149) | 2.71960903 |
| 101 | histone H4 deacetylation (GO:0070933) | 2.70895243 |
| 102 | maternal placenta development (GO:0001893) | 2.70192883 |
| 103 | B cell receptor signaling pathway (GO:0050853) | 2.69233659 |
| 104 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.68539239 |
| 105 | tricarboxylic acid metabolic process (GO:0072350) | 2.67093028 |
| 106 | actin filament depolymerization (GO:0030042) | 2.66982271 |
| 107 | DNA unwinding involved in DNA replication (GO:0006268) | 2.66832743 |
| 108 | leukocyte aggregation (GO:0070486) | 2.64863305 |
| 109 | Peyers patch development (GO:0048541) | 2.64427180 |
| 110 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.64427180 |
| 111 | positive regulation of Rap GTPase activity (GO:0032854) | 2.64254607 |
| 112 | positive regulation of protein deacetylation (GO:0090312) | 2.63873104 |
| 113 | desmosome organization (GO:0002934) | 2.62767040 |
| 114 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.62436099 |
| 115 | regulation of Rap GTPase activity (GO:0032317) | 2.62331527 |
| 116 | regulation of histone H3-K27 methylation (GO:0061085) | 2.61688182 |
| 117 | activation of JUN kinase activity (GO:0007257) | 2.61608312 |
| 118 | sarcomere organization (GO:0045214) | 2.61554761 |
| 119 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.61278067 |
| 120 | semaphorin-plexin signaling pathway (GO:0071526) | 2.60905035 |
| 121 | cell volume homeostasis (GO:0006884) | 2.59505249 |
| 122 | protein export from nucleus (GO:0006611) | 2.57788260 |
| 123 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.57759334 |
| 124 | cellular response to unfolded protein (GO:0034620) | 2.57414671 |
| 125 | adherens junction assembly (GO:0034333) | 2.56652780 |
| 126 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.56559608 |
| 127 | regulation of B cell differentiation (GO:0045577) | 2.56171827 |
| 128 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.55930030 |
| 129 | retrograde transport, endosome to Golgi (GO:0042147) | 2.55289289 |
| 130 | plasma membrane repair (GO:0001778) | 2.54718895 |
| 131 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.54632631 |
| 132 | ER-nucleus signaling pathway (GO:0006984) | 2.54531796 |
| 133 | positive regulation of nuclease activity (GO:0032075) | 2.54292079 |
| 134 | cellular response to zinc ion (GO:0071294) | 2.53489000 |
| 135 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.53071181 |
| 136 | cell-substrate adherens junction assembly (GO:0007045) | 2.53015691 |
| 137 | focal adhesion assembly (GO:0048041) | 2.53015691 |
| 138 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.52522925 |
| 139 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.51816083 |
| 140 | 4-hydroxyproline metabolic process (GO:0019471) | 2.50687118 |
| 141 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.50582866 |
| 142 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.49844161 |
| 143 | regulation of early endosome to late endosome transport (GO:2000641) | 2.49411969 |
| 144 | galactose catabolic process (GO:0019388) | 2.46090578 |
| 145 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.45685640 |
| 146 | cellular response to topologically incorrect protein (GO:0035967) | 2.45590107 |
| 147 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.45522015 |
| 148 | tricarboxylic acid cycle (GO:0006099) | 2.45237289 |
| 149 | activation of protein kinase A activity (GO:0034199) | 2.45132582 |
| 150 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.44007762 |
| 151 | protein insertion into membrane (GO:0051205) | 2.43548298 |
| 152 | cellular response to interleukin-4 (GO:0071353) | 2.42661872 |
| 153 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.40941413 |
| 154 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.40761019 |
| 155 | regulation of vacuole organization (GO:0044088) | 2.40464623 |
| 156 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.39520136 |
| 157 | folic acid metabolic process (GO:0046655) | 2.39318751 |
| 158 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.38604463 |
| 159 | cellular hyperosmotic response (GO:0071474) | 2.37316928 |
| 160 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.37050555 |
| 161 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.37050555 |
| 162 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.37050555 |
| 163 | protein localization to endosome (GO:0036010) | 2.37024459 |
| 164 | modulation by virus of host morphology or physiology (GO:0019048) | 2.36740871 |
| 165 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.35501239 |
| 166 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.35212795 |
| 167 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.34672753 |
| 168 | virion assembly (GO:0019068) | 2.34569211 |
| 169 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.34138313 |
| 170 | L-phenylalanine metabolic process (GO:0006558) | 2.34138313 |
| 171 | cellular response to interleukin-15 (GO:0071350) | 2.34111514 |
| 172 | megakaryocyte development (GO:0035855) | 2.34030339 |
| 173 | regulation of cholesterol homeostasis (GO:2000188) | 2.33930592 |
| 174 | mitotic chromosome condensation (GO:0007076) | 2.33658467 |
| 175 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.32749040 |
| 176 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.32461994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 3.79417491 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.06973942 |
| 3 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.81232151 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.72447630 |
| 5 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.46627955 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.42276124 |
| 7 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.34736071 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.32481333 |
| 9 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.31919481 |
| 10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.26190978 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23042062 |
| 12 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16919444 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.15825443 |
| 14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.13862826 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.11032204 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07881278 |
| 17 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01580488 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.00235251 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.99961928 |
| 20 | P68_20966046_ChIP-Seq_HELA_Human | 1.98034020 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.96961352 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94363526 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93365880 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86385132 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84637798 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.80050017 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.76511569 |
| 28 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.75770534 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.74392507 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73784521 |
| 31 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.73117387 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71920475 |
| 33 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.71085494 |
| 34 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.70134422 |
| 35 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.68792345 |
| 36 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.68447815 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.60793790 |
| 38 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.60757854 |
| 39 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.60456219 |
| 40 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59593879 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.58686148 |
| 42 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.58637736 |
| 43 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.58387550 |
| 44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.57694499 |
| 45 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51094777 |
| 46 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.48399556 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47464232 |
| 48 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47326569 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47254091 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44495065 |
| 51 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.43706865 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42181220 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41578667 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41185513 |
| 55 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.40244020 |
| 56 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.40099382 |
| 57 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.39480420 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39460764 |
| 59 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.38997800 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38756086 |
| 61 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.38725041 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38252534 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.37464351 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37350210 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35798156 |
| 66 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.35704503 |
| 67 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.35688529 |
| 68 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.35382538 |
| 69 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.34396255 |
| 70 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.33987190 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.33117806 |
| 72 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.31793056 |
| 73 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.31168320 |
| 74 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.29940114 |
| 75 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28772273 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27571952 |
| 77 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.27563475 |
| 78 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26738748 |
| 79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25503426 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24397942 |
| 81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.24015173 |
| 82 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.23322175 |
| 83 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22206095 |
| 84 | SA1_27219007_Chip-Seq_Bcells_Human | 1.22193184 |
| 85 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22141244 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21831416 |
| 87 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21707457 |
| 88 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.21698013 |
| 89 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.21193419 |
| 90 | MYB_26560356_Chip-Seq_TH2_Human | 1.19693879 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.19068099 |
| 92 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.18764198 |
| 93 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18757839 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18455547 |
| 95 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18436967 |
| 96 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.17204147 |
| 97 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.17171846 |
| 98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16861553 |
| 99 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.16505157 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16363865 |
| 101 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15670709 |
| 102 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.15271077 |
| 103 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14946702 |
| 104 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14485030 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14423409 |
| 106 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.14265024 |
| 107 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14173681 |
| 108 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14171005 |
| 109 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.13870181 |
| 110 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13596756 |
| 111 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13590230 |
| 112 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12486364 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12049893 |
| 114 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.11336115 |
| 115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11177996 |
| 116 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11036017 |
| 117 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.10917719 |
| 118 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10671568 |
| 119 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10166251 |
| 120 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10090910 |
| 121 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09556552 |
| 122 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09192104 |
| 123 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08885503 |
| 124 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.08401172 |
| 125 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07399503 |
| 126 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07214573 |
| 127 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07140621 |
| 128 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.05800450 |
| 129 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05750120 |
| 130 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05513490 |
| 131 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.05393359 |
| 132 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04732043 |
| 133 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04572602 |
| 134 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.04011784 |
| 135 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03266595 |
| 136 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.03235318 |
| 137 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02712939 |
| 138 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02459161 |
| 139 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.02325323 |
| 140 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02163510 |
| 141 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.01892592 |
| 142 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.01734510 |
| 143 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01287528 |
| 144 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00633515 |
| 145 | MYB_26560356_Chip-Seq_TH1_Human | 1.00137693 |
| 146 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00118360 |
| 147 | P300_27268052_Chip-Seq_Bcells_Human | 0.99577344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.42235006 |
| 2 | MP0008260_abnormal_autophagy | 3.82429190 |
| 3 | MP0005451_abnormal_body_composition | 3.72274031 |
| 4 | MP0003303_peritoneal_inflammation | 2.68783137 |
| 5 | MP0008961_abnormal_basal_metabolism | 2.64235488 |
| 6 | MP0004381_abnormal_hair_follicle | 2.53652762 |
| 7 | MP0000685_abnormal_immune_system | 2.52564781 |
| 8 | MP0005409_darkened_coat_color | 2.42486338 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.41695749 |
| 10 | MP0000751_myopathy | 2.37778501 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.29040808 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.17161265 |
| 13 | MP0009278_abnormal_bone_marrow | 2.16682960 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.15586269 |
| 15 | MP0002822_catalepsy | 2.10114701 |
| 16 | MP0000749_muscle_degeneration | 2.09751806 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 2.08833327 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.06724451 |
| 19 | MP0009840_abnormal_foam_cell | 2.01068707 |
| 20 | MP0001849_ear_inflammation | 2.00582470 |
| 21 | MP0003329_amyloid_beta_deposits | 1.98756259 |
| 22 | MP0003436_decreased_susceptibility_to | 1.90726868 |
| 23 | MP0003646_muscle_fatigue | 1.88680854 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.86120378 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.84332327 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.83470589 |
| 27 | MP0001730_embryonic_growth_arrest | 1.77459413 |
| 28 | MP0004510_myositis | 1.75715465 |
| 29 | MP0004858_abnormal_nervous_system | 1.74035253 |
| 30 | MP0005666_abnormal_adipose_tissue | 1.71870841 |
| 31 | MP0000747_muscle_weakness | 1.69130152 |
| 32 | MP0002398_abnormal_bone_marrow | 1.68590261 |
| 33 | MP0003635_abnormal_synaptic_transmissio | 1.61133051 |
| 34 | MP0001873_stomach_inflammation | 1.59893649 |
| 35 | MP0005671_abnormal_response_to | 1.58908266 |
| 36 | MP0002269_muscular_atrophy | 1.58105174 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.56398052 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.56398052 |
| 39 | MP0003111_abnormal_nucleus_morphology | 1.55042251 |
| 40 | MP0002132_abnormal_respiratory_system | 1.54868031 |
| 41 | MP0002653_abnormal_ependyma_morphology | 1.50056109 |
| 42 | MP0003075_altered_response_to | 1.49562383 |
| 43 | MP0001800_abnormal_humoral_immune | 1.48395191 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.47641652 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.45976971 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.43639127 |
| 47 | MP0004036_abnormal_muscle_relaxation | 1.43557523 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.41838038 |
| 49 | MP0004130_abnormal_muscle_cell | 1.41789063 |
| 50 | MP0002796_impaired_skin_barrier | 1.40888219 |
| 51 | MP0001819_abnormal_immune_cell | 1.40502153 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.40093899 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.38441312 |
| 54 | MP0005000_abnormal_immune_tolerance | 1.37758554 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.36182946 |
| 56 | MP0008569_lethality_at_weaning | 1.35301280 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 1.34935825 |
| 58 | MP0002089_abnormal_postnatal_growth/wei | 1.34666045 |
| 59 | MP0005670_abnormal_white_adipose | 1.34480871 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.32950438 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.32644660 |
| 62 | MP0005387_immune_system_phenotype | 1.32524615 |
| 63 | MP0001790_abnormal_immune_system | 1.32524615 |
| 64 | MP0004087_abnormal_muscle_fiber | 1.32153432 |
| 65 | MP0005083_abnormal_biliary_tract | 1.31799753 |
| 66 | MP0002722_abnormal_immune_system | 1.31478026 |
| 67 | MP0000716_abnormal_immune_system | 1.31353869 |
| 68 | MP0005501_abnormal_skin_physiology | 1.30565866 |
| 69 | MP0002452_abnormal_antigen_presenting | 1.28200412 |
| 70 | MP0000013_abnormal_adipose_tissue | 1.26644893 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 1.25308051 |
| 72 | MP0002429_abnormal_blood_cell | 1.25039988 |
| 73 | MP0002723_abnormal_immune_serum | 1.24391523 |
| 74 | MP0000678_abnormal_parathyroid_gland | 1.24210758 |
| 75 | MP0001348_abnormal_lacrimal_gland | 1.22858997 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.22541714 |
| 77 | MP0005330_cardiomyopathy | 1.21894809 |
| 78 | MP0003693_abnormal_embryo_hatching | 1.21710677 |
| 79 | MP0005621_abnormal_cell_physiology | 1.19879406 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 1.19461083 |
| 81 | MP0003077_abnormal_cell_cycle | 1.19034806 |
| 82 | MP0000604_amyloidosis | 1.19031331 |
| 83 | MP0005025_abnormal_response_to | 1.18852410 |
| 84 | MP0003191_abnormal_cellular_cholesterol | 1.15818963 |
| 85 | MP0002080_prenatal_lethality | 1.14101577 |
| 86 | MP0003315_abnormal_perineum_morphology | 1.13379553 |
| 87 | MP0009672_abnormal_birth_weight | 1.12479148 |
| 88 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11189308 |
| 89 | MP0005408_hypopigmentation | 1.10362235 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 1.10271071 |
| 91 | MP0000358_abnormal_cell_content/ | 1.09590366 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 1.07453542 |
| 93 | MP0002735_abnormal_chemical_nociception | 1.07193358 |
| 94 | MP0003866_abnormal_defecation | 1.06308147 |
| 95 | MP0000003_abnormal_adipose_tissue | 1.06127075 |
| 96 | MP0009931_abnormal_skin_appearance | 1.06126801 |
| 97 | MP0000377_abnormal_hair_follicle | 1.05202297 |
| 98 | MP0002064_seizures | 1.05007656 |
| 99 | MP0003137_abnormal_impulse_conducting | 1.03367171 |
| 100 | MP0004811_abnormal_neuron_physiology | 1.02880873 |
| 101 | MP0002419_abnormal_innate_immunity | 1.02659094 |
| 102 | MP0000759_abnormal_skeletal_muscle | 1.02241195 |
| 103 | MP0010352_gastrointestinal_tract_polyps | 1.01994894 |
| 104 | MP0003279_aneurysm | 1.01852770 |
| 105 | MP0005166_decreased_susceptibility_to | 1.01508407 |
| 106 | MP0002166_altered_tumor_susceptibility | 1.00855412 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 1.00099017 |
| 108 | MP0002009_preneoplasia | 0.98609351 |
| 109 | MP0004233_abnormal_muscle_weight | 0.98173508 |
| 110 | MP0005171_absent_coat_pigmentation | 0.96550925 |
| 111 | MP0004270_analgesia | 0.95927667 |
| 112 | MP0001533_abnormal_skeleton_physiology | 0.95548087 |
| 113 | MP0005384_cellular_phenotype | 0.95344082 |
| 114 | MP0001216_abnormal_epidermal_layer | 0.94763856 |
| 115 | MP0002060_abnormal_skin_morphology | 0.93734855 |
| 116 | MP0003705_abnormal_hypodermis_morpholog | 0.93535353 |
| 117 | MP0000537_abnormal_urethra_morphology | 0.93345926 |
| 118 | MP0002933_joint_inflammation | 0.92012261 |
| 119 | MP0003453_abnormal_keratinocyte_physiol | 0.91343817 |
| 120 | MP0010630_abnormal_cardiac_muscle | 0.90009924 |
| 121 | MP0002970_abnormal_white_adipose | 0.88432692 |
| 122 | MP0009785_altered_susceptibility_to | 0.87045073 |
| 123 | MP0001968_abnormal_touch/_nociception | 0.86884838 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.86000465 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.85641511 |
| 126 | MP0000609_abnormal_liver_physiology | 0.85025205 |
| 127 | MP0010234_abnormal_vibrissa_follicle | 0.84830303 |
| 128 | MP0003879_abnormal_hair_cell | 0.84132375 |
| 129 | MP0000371_diluted_coat_color | 0.83744568 |
| 130 | MP0003123_paternal_imprinting | 0.82829538 |
| 131 | MP0005220_abnormal_exocrine_pancreas | 0.82777899 |
| 132 | MP0002249_abnormal_larynx_morphology | 0.82278812 |
| 133 | MP0005076_abnormal_cell_differentiation | 0.82050460 |
| 134 | MP0002063_abnormal_learning/memory/cond | 0.82035205 |
| 135 | MP0004215_abnormal_myocardial_fiber | 0.81140147 |
| 136 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80939121 |
| 137 | MP0002086_abnormal_extraembryonic_tissu | 0.80797049 |
| 138 | MP0001727_abnormal_embryo_implantation | 0.80243415 |
| 139 | MP0001845_abnormal_inflammatory_respons | 0.80096905 |
| 140 | MP0000350_abnormal_cell_proliferation | 0.78831349 |
| 141 | MP0002234_abnormal_pharynx_morphology | 0.78548570 |
| 142 | MP0001346_abnormal_lacrimal_gland | 0.78002296 |
| 143 | MP0000681_abnormal_thyroid_gland | 0.77939774 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.77565251 |
| 145 | MP0002736_abnormal_nociception_after | 0.76288369 |
| 146 | MP0001661_extended_life_span | 0.75452686 |
| 147 | MP0003045_fibrosis | 0.75241024 |
| 148 | MP0002106_abnormal_muscle_physiology | 0.74722242 |
| 149 | MP0010155_abnormal_intestine_physiology | 0.74560754 |
| 150 | MP0004947_skin_inflammation | 0.74186714 |
| 151 | MP0000313_abnormal_cell_death | 0.73001727 |
| 152 | MP0002971_abnormal_brown_adipose | 0.72757388 |
| 153 | MP0003984_embryonic_growth_retardation | 0.70479333 |
| 154 | MP0000733_abnormal_muscle_development | 0.68295961 |
| 155 | MP0005365_abnormal_bile_salt | 0.67083845 |
| 156 | MP0003136_yellow_coat_color | 0.67034970 |
| 157 | MP0001697_abnormal_embryo_size | 0.66064296 |
| 158 | MP0005380_embryogenesis_phenotype | 0.65402324 |
| 159 | MP0001672_abnormal_embryogenesis/_devel | 0.65402324 |
| 160 | MP0001666_abnormal_nutrient_absorption | 0.65198416 |
| 161 | MP0008932_abnormal_embryonic_tissue | 0.64767607 |
| 162 | MP0000462_abnormal_digestive_system | 0.64652916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperacusis (HP:0010780) | 4.44715888 |
| 2 | Cholecystitis (HP:0001082) | 4.39460727 |
| 3 | Abnormal gallbladder physiology (HP:0012438) | 4.39460727 |
| 4 | Insomnia (HP:0100785) | 3.77788402 |
| 5 | Abnormality of the lower motor neuron (HP:0002366) | 3.67501656 |
| 6 | Exercise-induced myalgia (HP:0003738) | 3.19431427 |
| 7 | Myopathic facies (HP:0002058) | 3.12875561 |
| 8 | Ragged-red muscle fibers (HP:0003200) | 3.03163621 |
| 9 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.01064286 |
| 10 | Elfin facies (HP:0004428) | 2.97866631 |
| 11 | Reticulocytosis (HP:0001923) | 2.88844278 |
| 12 | Myoglobinuria (HP:0002913) | 2.87572111 |
| 13 | Distal lower limb amyotrophy (HP:0008944) | 2.80106919 |
| 14 | J-shaped sella turcica (HP:0002680) | 2.75091441 |
| 15 | Growth hormone excess (HP:0000845) | 2.72354661 |
| 16 | Bundle branch block (HP:0011710) | 2.65422686 |
| 17 | Deep venous thrombosis (HP:0002625) | 2.65239621 |
| 18 | Abnormality of the nasal mucosa (HP:0000433) | 2.64580168 |
| 19 | Limb-girdle muscle atrophy (HP:0003797) | 2.64238385 |
| 20 | Cellulitis (HP:0100658) | 2.60217267 |
| 21 | Distal upper limb amyotrophy (HP:0007149) | 2.56895500 |
| 22 | Upper limb amyotrophy (HP:0009129) | 2.56895500 |
| 23 | Sudden death (HP:0001699) | 2.56399151 |
| 24 | Recurrent bronchitis (HP:0002837) | 2.51800170 |
| 25 | Overriding aorta (HP:0002623) | 2.50719220 |
| 26 | Cerebral aneurysm (HP:0004944) | 2.48408601 |
| 27 | Cholelithiasis (HP:0001081) | 2.43124826 |
| 28 | Difficulty climbing stairs (HP:0003551) | 2.41754783 |
| 29 | Polycythemia (HP:0001901) | 2.40374050 |
| 30 | Peripheral hypomyelination (HP:0007182) | 2.38930558 |
| 31 | Supranuclear gaze palsy (HP:0000605) | 2.36578780 |
| 32 | Distal lower limb muscle weakness (HP:0009053) | 2.36075598 |
| 33 | Poikiloderma (HP:0001029) | 2.35033543 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 2.34449513 |
| 35 | Seborrheic dermatitis (HP:0001051) | 2.32231022 |
| 36 | Chronic otitis media (HP:0000389) | 2.31237054 |
| 37 | Asymmetric septal hypertrophy (HP:0001670) | 2.31007057 |
| 38 | Verrucae (HP:0200043) | 2.30864295 |
| 39 | Papilloma (HP:0012740) | 2.30864295 |
| 40 | Hand muscle atrophy (HP:0009130) | 2.30551531 |
| 41 | Neoplasm of the heart (HP:0100544) | 2.29798952 |
| 42 | Foot dorsiflexor weakness (HP:0009027) | 2.28646382 |
| 43 | Increased variability in muscle fiber diameter (HP:0003557) | 2.28532052 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.25746667 |
| 45 | Hammertoe (HP:0001765) | 2.24006309 |
| 46 | Ventricular fibrillation (HP:0001663) | 2.23337255 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23323973 |
| 48 | Increased connective tissue (HP:0009025) | 2.23234870 |
| 49 | High pitched voice (HP:0001620) | 2.22470710 |
| 50 | Death in childhood (HP:0003819) | 2.21788885 |
| 51 | Myokymia (HP:0002411) | 2.21208523 |
| 52 | Orthostatic hypotension (HP:0001278) | 2.19281042 |
| 53 | Ankle clonus (HP:0011448) | 2.18704611 |
| 54 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.17996519 |
| 55 | Subaortic stenosis (HP:0001682) | 2.17996519 |
| 56 | Hypercortisolism (HP:0001578) | 2.16259840 |
| 57 | Renovascular hypertension (HP:0100817) | 2.15619813 |
| 58 | Diminished motivation (HP:0000745) | 2.15451940 |
| 59 | Apathy (HP:0000741) | 2.14844720 |
| 60 | Rapidly progressive (HP:0003678) | 2.13642223 |
| 61 | Alacrima (HP:0000522) | 2.10731995 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.10393473 |
| 63 | Dysmetric saccades (HP:0000641) | 2.08990804 |
| 64 | Nasal polyposis (HP:0100582) | 2.08477624 |
| 65 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.06565183 |
| 66 | Pointed chin (HP:0000307) | 2.05126814 |
| 67 | Abnormality of glycolysis (HP:0004366) | 2.04397229 |
| 68 | Back pain (HP:0003418) | 2.03948883 |
| 69 | Gastrointestinal dysmotility (HP:0002579) | 2.03782484 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.01778123 |
| 71 | Abnormality of the foot musculature (HP:0001436) | 2.01615087 |
| 72 | Achilles tendon contracture (HP:0001771) | 2.01039558 |
| 73 | Right ventricular cardiomyopathy (HP:0011663) | 2.00872028 |
| 74 | Hemorrhage of the eye (HP:0011885) | 1.99728861 |
| 75 | Depression (HP:0000716) | 1.99524297 |
| 76 | Ventricular tachycardia (HP:0004756) | 1.99350458 |
| 77 | Frequent falls (HP:0002359) | 1.94450025 |
| 78 | Chest pain (HP:0100749) | 1.94214152 |
| 79 | Aneurysm (HP:0002617) | 1.94035363 |
| 80 | Abnormality of the gallbladder (HP:0005264) | 1.93696395 |
| 81 | Striae distensae (HP:0001065) | 1.92491197 |
| 82 | Microvesicular hepatic steatosis (HP:0001414) | 1.91925477 |
| 83 | Exercise-induced muscle cramps (HP:0003710) | 1.90903812 |
| 84 | Thoracic kyphosis (HP:0002942) | 1.90653669 |
| 85 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.90217405 |
| 86 | Hypoventilation (HP:0002791) | 1.89541830 |
| 87 | Dysostosis multiplex (HP:0000943) | 1.89540650 |
| 88 | Bowel diverticulosis (HP:0005222) | 1.89434995 |
| 89 | Termporal pattern (HP:0011008) | 1.89354827 |
| 90 | Insidious onset (HP:0003587) | 1.89354827 |
| 91 | Eczematoid dermatitis (HP:0000976) | 1.89340386 |
| 92 | Visual hallucinations (HP:0002367) | 1.88512497 |
| 93 | Obstructive sleep apnea (HP:0002870) | 1.87670688 |
| 94 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.86621677 |
| 95 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.86621677 |
| 96 | Neuronal loss in central nervous system (HP:0002529) | 1.85641871 |
| 97 | Difficulty running (HP:0009046) | 1.85584057 |
| 98 | Advanced eruption of teeth (HP:0006288) | 1.85220961 |
| 99 | Rhabdomyolysis (HP:0003201) | 1.84435957 |
| 100 | Bladder diverticulum (HP:0000015) | 1.84221993 |
| 101 | Progressive microcephaly (HP:0000253) | 1.84062504 |
| 102 | Cerebral palsy (HP:0100021) | 1.83843548 |
| 103 | Late onset (HP:0003584) | 1.83826101 |
| 104 | Colitis (HP:0002583) | 1.83656125 |
| 105 | Progressive muscle weakness (HP:0003323) | 1.83062012 |
| 106 | Vertebral compression fractures (HP:0002953) | 1.82644414 |
| 107 | Amyotrophic lateral sclerosis (HP:0007354) | 1.81905411 |
| 108 | Abnormality of the Achilles tendon (HP:0005109) | 1.81550144 |
| 109 | Papilledema (HP:0001085) | 1.81139855 |
| 110 | Insulin resistance (HP:0000855) | 1.80802222 |
| 111 | Fatigue (HP:0012378) | 1.80642045 |
| 112 | Flat cornea (HP:0007720) | 1.80240787 |
| 113 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.80187346 |
| 114 | Thrombocytosis (HP:0001894) | 1.80154449 |
| 115 | Systemic lupus erythematosus (HP:0002725) | 1.79835470 |
| 116 | Annular pancreas (HP:0001734) | 1.79433558 |
| 117 | Recurrent viral infections (HP:0004429) | 1.79060949 |
| 118 | Athetosis (HP:0002305) | 1.78701130 |
| 119 | Atelectasis (HP:0100750) | 1.78698769 |
| 120 | Gout (HP:0001997) | 1.78672556 |
| 121 | Distal sensory impairment (HP:0002936) | 1.78641637 |
| 122 | Urinary urgency (HP:0000012) | 1.78244854 |
| 123 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.78184837 |
| 124 | Upper limb muscle weakness (HP:0003484) | 1.78182222 |
| 125 | Global brain atrophy (HP:0002283) | 1.77919864 |
| 126 | Abnormal neuron morphology (HP:0012757) | 1.76552292 |
| 127 | Abnormality of the motor neurons (HP:0002450) | 1.76552292 |
| 128 | Severe short stature (HP:0003510) | 1.76286994 |
| 129 | Long toe (HP:0010511) | 1.75877802 |
| 130 | Abnormality of the thoracic spine (HP:0100711) | 1.75691593 |
| 131 | Flat acetabular roof (HP:0003180) | 1.75502756 |
| 132 | Lower limb amyotrophy (HP:0007210) | 1.75348426 |
| 133 | Asymmetry of the thorax (HP:0001555) | 1.74874704 |
| 134 | Loss of speech (HP:0002371) | 1.74500631 |
| 135 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.74470159 |
| 136 | Renal duplication (HP:0000075) | 1.74388320 |
| 137 | Aortic aneurysm (HP:0004942) | 1.74099215 |
| 138 | Myotonia (HP:0002486) | 1.73928595 |
| 139 | Hemiplegia (HP:0002301) | 1.73730415 |
| 140 | Germ cell neoplasia (HP:0100728) | 1.73313525 |
| 141 | Precocious puberty (HP:0000826) | 1.73069384 |
| 142 | Interstitial pulmonary disease (HP:0006530) | 1.71342223 |
| 143 | Recurrent fungal infections (HP:0002841) | 1.71127666 |
| 144 | Mucopolysacchariduria (HP:0008155) | 1.70113931 |
| 145 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.70113931 |
| 146 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.69127661 |
| 147 | Recurrent abscess formation (HP:0002722) | 1.68788131 |
| 148 | Urticaria (HP:0001025) | 1.68786011 |
| 149 | Abnormal social behavior (HP:0012433) | 1.67362111 |
| 150 | Impaired social interactions (HP:0000735) | 1.67362111 |
| 151 | Abnormality of pain sensation (HP:0010832) | 1.66921164 |
| 152 | Impaired pain sensation (HP:0007328) | 1.66921164 |
| 153 | Decreased motor nerve conduction velocity (HP:0003431) | 1.66754658 |
| 154 | Long palpebral fissure (HP:0000637) | 1.65868683 |
| 155 | Lymphangioma (HP:0100764) | 1.65309011 |
| 156 | Deformed sella turcica (HP:0002681) | 1.64819487 |
| 157 | Stridor (HP:0010307) | 1.64645433 |
| 158 | Impaired smooth pursuit (HP:0007772) | 1.64593508 |
| 159 | Easy fatigability (HP:0003388) | 1.64532594 |
| 160 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.64530401 |
| 161 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.64530401 |
| 162 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.64530401 |
| 163 | Flattened epiphyses (HP:0003071) | 1.64371654 |
| 164 | Diaphragmatic weakness (HP:0009113) | 1.63824429 |
| 165 | Cardiomegaly (HP:0001640) | 1.63713799 |
| 166 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.62042727 |
| 167 | Prolonged neonatal jaundice (HP:0006579) | 1.61155669 |
| 168 | Truncus arteriosus (HP:0001660) | 1.60883556 |
| 169 | Bowel incontinence (HP:0002607) | 1.60550492 |
| 170 | Cerebral inclusion bodies (HP:0100314) | 1.60193131 |
| 171 | Ileus (HP:0002595) | 1.59769967 |
| 172 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.58215788 |
| 173 | Spinal rigidity (HP:0003306) | 1.58087401 |
| 174 | EMG: myopathic abnormalities (HP:0003458) | 1.57900080 |
| 175 | Macroorchidism (HP:0000053) | 1.57495027 |
| 176 | Cervical subluxation (HP:0003308) | 1.56866333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 4.50060744 |
| 2 | TRIB3 | 4.31483358 |
| 3 | MAP3K10 | 3.68926065 |
| 4 | PKN2 | 3.04034136 |
| 5 | ERN1 | 2.78449222 |
| 6 | CDK12 | 2.72591695 |
| 7 | EEF2K | 2.59854772 |
| 8 | SMG1 | 2.57340827 |
| 9 | MAP4K1 | 2.52251092 |
| 10 | PRPF4B | 2.43018947 |
| 11 | MAP3K9 | 2.35899020 |
| 12 | TESK2 | 2.27662409 |
| 13 | PRKD3 | 2.05605181 |
| 14 | NME2 | 1.93124391 |
| 15 | TTN | 1.68907891 |
| 16 | FGFR4 | 1.64906902 |
| 17 | EPHA2 | 1.54611077 |
| 18 | TAOK1 | 1.42930066 |
| 19 | NEK1 | 1.42255254 |
| 20 | EIF2AK1 | 1.41366290 |
| 21 | ICK | 1.40160311 |
| 22 | ZAP70 | 1.38742580 |
| 23 | PHKG1 | 1.37209481 |
| 24 | PHKG2 | 1.37209481 |
| 25 | SIK2 | 1.33916231 |
| 26 | MTOR | 1.31213818 |
| 27 | IRAK3 | 1.30160200 |
| 28 | KDR | 1.29313581 |
| 29 | TESK1 | 1.26560735 |
| 30 | NTRK3 | 1.25760277 |
| 31 | MARK3 | 1.21539103 |
| 32 | GRK6 | 1.20356320 |
| 33 | DAPK1 | 1.19174048 |
| 34 | SIK3 | 1.18888009 |
| 35 | STK38 | 1.16756157 |
| 36 | MAP3K7 | 1.16321333 |
| 37 | KSR2 | 1.15268586 |
| 38 | PDGFRA | 1.12861705 |
| 39 | LIMK1 | 1.10728018 |
| 40 | TYK2 | 1.08795443 |
| 41 | PTK6 | 1.08396031 |
| 42 | RIPK1 | 1.07285465 |
| 43 | EPHA4 | 1.07090135 |
| 44 | CAMKK1 | 1.05003530 |
| 45 | DAPK2 | 1.04419476 |
| 46 | MST1R | 1.03895513 |
| 47 | FES | 1.01041826 |
| 48 | TYRO3 | 0.99585537 |
| 49 | LRRK2 | 0.98171470 |
| 50 | BTK | 0.98125152 |
| 51 | BLK | 0.97572170 |
| 52 | SYK | 0.95031319 |
| 53 | MAP3K2 | 0.94735691 |
| 54 | PAK6 | 0.93201281 |
| 55 | LMTK2 | 0.91798952 |
| 56 | ALK | 0.90874962 |
| 57 | RET | 0.90368128 |
| 58 | BMX | 0.88504361 |
| 59 | NTRK1 | 0.87780051 |
| 60 | PBK | 0.87459211 |
| 61 | DAPK3 | 0.87371253 |
| 62 | RPS6KB2 | 0.86498102 |
| 63 | PTK2 | 0.86275372 |
| 64 | NEK6 | 0.85652499 |
| 65 | TSSK6 | 0.84836271 |
| 66 | TBK1 | 0.83565584 |
| 67 | TLK1 | 0.82731014 |
| 68 | MAP3K4 | 0.81176096 |
| 69 | TNK2 | 0.80782006 |
| 70 | DMPK | 0.80347722 |
| 71 | MAPKAPK3 | 0.80121385 |
| 72 | MAP2K4 | 0.79823962 |
| 73 | PRKCH | 0.77237936 |
| 74 | CSK | 0.76982831 |
| 75 | PRKG2 | 0.76370960 |
| 76 | NME1 | 0.76334456 |
| 77 | DYRK1B | 0.75898483 |
| 78 | MAP2K2 | 0.75564840 |
| 79 | MAP3K6 | 0.74791454 |
| 80 | STK10 | 0.74751341 |
| 81 | CDK7 | 0.72322366 |
| 82 | MAP3K11 | 0.72306597 |
| 83 | HCK | 0.72160735 |
| 84 | MAP2K7 | 0.71379044 |
| 85 | ILK | 0.70243949 |
| 86 | BRSK1 | 0.69554890 |
| 87 | EPHB1 | 0.69494595 |
| 88 | BCKDK | 0.68789155 |
| 89 | MAP2K3 | 0.68737921 |
| 90 | FLT3 | 0.67928478 |
| 91 | TAOK2 | 0.67655770 |
| 92 | HIPK2 | 0.66916879 |
| 93 | MINK1 | 0.65653615 |
| 94 | MARK2 | 0.65273943 |
| 95 | JAK3 | 0.65205017 |
| 96 | MAP3K13 | 0.64729126 |
| 97 | VRK2 | 0.64287099 |
| 98 | KIT | 0.63777021 |
| 99 | MAP3K3 | 0.62954360 |
| 100 | NTRK2 | 0.62167641 |
| 101 | PDK3 | 0.61926591 |
| 102 | PDK4 | 0.61926591 |
| 103 | MAP3K8 | 0.61743160 |
| 104 | CDC42BPA | 0.61047103 |
| 105 | JAK1 | 0.60615269 |
| 106 | PRKD1 | 0.59746384 |
| 107 | SCYL2 | 0.58267260 |
| 108 | PRKD2 | 0.57769582 |
| 109 | TGFBR1 | 0.57550686 |
| 110 | NEK2 | 0.57412723 |
| 111 | ARAF | 0.57096323 |
| 112 | MAP2K6 | 0.56512529 |
| 113 | ITK | 0.56498052 |
| 114 | MAP3K1 | 0.55643827 |
| 115 | JAK2 | 0.53153922 |
| 116 | CDK11A | 0.52508526 |
| 117 | CAMKK2 | 0.51948664 |
| 118 | PAK4 | 0.51299849 |
| 119 | CAMK1 | 0.51143362 |
| 120 | PDPK1 | 0.51021817 |
| 121 | KSR1 | 0.50967023 |
| 122 | PDK1 | 0.48889148 |
| 123 | CDK14 | 0.48700213 |
| 124 | MAPK11 | 0.48085998 |
| 125 | MARK1 | 0.47946500 |
| 126 | CDK6 | 0.47945469 |
| 127 | AKT2 | 0.47810459 |
| 128 | FER | 0.47661145 |
| 129 | MAPK12 | 0.47007411 |
| 130 | CDK4 | 0.46581217 |
| 131 | CDK9 | 0.46397206 |
| 132 | RPS6KA2 | 0.44709523 |
| 133 | TNIK | 0.43237566 |
| 134 | PINK1 | 0.42626624 |
| 135 | MAPK10 | 0.42339071 |
| 136 | SIK1 | 0.42300467 |
| 137 | CDK15 | 0.41446873 |
| 138 | CDK5 | 0.41040267 |
| 139 | RIPK4 | 0.39728971 |
| 140 | CDK18 | 0.38210875 |
| 141 | LCK | 0.37509034 |
| 142 | CHEK1 | 0.36979265 |
| 143 | CCNB1 | 0.34187480 |
| 144 | PRKAA1 | 0.32986825 |
| 145 | PIM2 | 0.32841777 |
| 146 | RAF1 | 0.31986726 |
| 147 | AURKA | 0.31828459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.53758998 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.43962301 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.41717650 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.22239729 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.07523217 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.04537548 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97729394 |
| 8 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.92092860 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.89954315 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.89005825 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88174816 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.86455470 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73691664 |
| 14 | Thyroid cancer_Homo sapiens_hsa05216 | 1.57912711 |
| 15 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.57892284 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.51824382 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48700875 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.48374623 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.47204331 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.46115249 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44331562 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42276920 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40453234 |
| 24 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.37463882 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.35376126 |
| 26 | Endometrial cancer_Homo sapiens_hsa05213 | 1.33684086 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31311138 |
| 28 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.28764196 |
| 29 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28571559 |
| 30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.27351526 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.26412594 |
| 32 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.24370168 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21832793 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21640797 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20879429 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20445527 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.19920129 |
| 38 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.18849057 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.17963394 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.17942293 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 1.17413185 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16363269 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15833778 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15151953 |
| 45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.13993604 |
| 46 | Insulin resistance_Homo sapiens_hsa04931 | 1.12311095 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11869477 |
| 48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.10815143 |
| 49 | Long-term potentiation_Homo sapiens_hsa04720 | 1.10794892 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10755518 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10728831 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 1.10151924 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09387645 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 1.08977890 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06671237 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05756488 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 1.02283515 |
| 58 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.01435010 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98687761 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98192942 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98113902 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97391359 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96695957 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96356758 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93703651 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.93370089 |
| 67 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92026300 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90323780 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.88681455 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88122760 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87309144 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87156136 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87120877 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.86616966 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86247748 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85836654 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85562469 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.85030523 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84667226 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.83711859 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.83489341 |
| 82 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83230903 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82993276 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.82303990 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81714138 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.79476001 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78946115 |
| 88 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78838628 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.77795061 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76188776 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75227836 |
| 92 | Base excision repair_Homo sapiens_hsa03410 | 0.74668258 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.74134077 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.74120678 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.73787061 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73252869 |
| 97 | Gap junction_Homo sapiens_hsa04540 | 0.72469344 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.72204623 |
| 99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71755884 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69912489 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69545430 |
| 102 | Morphine addiction_Homo sapiens_hsa05032 | 0.68562467 |
| 103 | Apoptosis_Homo sapiens_hsa04210 | 0.68354372 |
| 104 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66770509 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66588542 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66308823 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.66301350 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65538257 |
| 109 | Measles_Homo sapiens_hsa05162 | 0.65266366 |
| 110 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65047139 |
| 111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.64642336 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64541338 |
| 113 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.64178155 |
| 114 | Hepatitis B_Homo sapiens_hsa05161 | 0.63868680 |
| 115 | Spliceosome_Homo sapiens_hsa03040 | 0.62698794 |
| 116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62286029 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61563717 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61017133 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.60560211 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58805990 |
| 121 | Bile secretion_Homo sapiens_hsa04976 | 0.58062541 |
| 122 | DNA replication_Homo sapiens_hsa03030 | 0.57842658 |
| 123 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57387770 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57094665 |
| 125 | Salivary secretion_Homo sapiens_hsa04970 | 0.56475996 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55286153 |
| 127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54516208 |
| 128 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54485547 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54236361 |
| 130 | Prostate cancer_Homo sapiens_hsa05215 | 0.53616183 |
| 131 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52349027 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52331125 |
| 133 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48557777 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46870831 |
| 135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45431266 |
| 136 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45365565 |
| 137 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45051759 |
| 138 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43827436 |
| 139 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42396933 |
| 140 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41542068 |
| 141 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41472494 |
| 142 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39227885 |
| 143 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37511234 |

